Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study

NCT ID: NCT07148934

Last Updated: 2025-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-15

Study Completion Date

2027-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the reliability of smartphone seismocardiography (SCG) and bed-based ballistocardiography (BCG) for detecting supraventricular tachycardia (SVT) in children aged 0-10 years. The performance of these methods will be compared to the gold standard of continuous telemetry ECG recording.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to validate the use of a cardiac monitoring system, comprising a smartphone for seismocardiography (SCG) and a smart mattress for ballistocardiography (BCG), to detect supraventricular tachycardia (SVT) in children aged 0-10 years. Additionally, the study will compare heart rate and breathing rate measurements from these investigational devices against a Philips Intellivue X2 ECG Monitor, which serves as the gold standard. A convenience sample of up to 60 children (30 in the SVT group and 30 in the control group) will be recruited, and their parents will also be interviewed to explore their perceptions of arrhythmia monitoring. The primary objective is to develop and understand algorithms for differentiating SVT from sinus rhythm using SCG and BCG signals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Supraventricular Tachycardia Atrial Fibrillation (AF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study( SVT) Group

Children aged 0-10 years treated in the pediatric wards of Tyks Lighthouse Hospital with diagnosed or suspected supraventricular tachycardia (SVT).

Smartphone seismographic recording and Bed Based Ballistocardiographic recordings

Intervention Type DIAGNOSTIC_TEST

A short recording of heart rhythm using a smartphone and bed-based ballistocardiogram.

Control Group

Children aged 0-10 years treated in the pediatric wards of Tyks Lighthouse hospital who have not been diagnosed with SVT (i.e., have a normal sinus rhythm).

Smartphone seismographic recording and Bed Based Ballistocardiographic recordings

Intervention Type DIAGNOSTIC_TEST

A short recording of heart rhythm using a smartphone and bed-based ballistocardiogram.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smartphone seismographic recording and Bed Based Ballistocardiographic recordings

A short recording of heart rhythm using a smartphone and bed-based ballistocardiogram.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For children in Study(SVT) group:

1. received informed consent from both parents/guardians
2. the child is treated in the Pediatric wards of Tyks Lighthouse hospital
3. the child is between the age of 0-10 years
4. the child has diagnosed or suspected SVT.
* For children in control group:

1. received informed consent from both parents/guardians
2. the child is treated in the Pediatric wards of Tyks Lighthouse hospital
3. the child is between the age of 0-10 years
4. child has not diagnosed with SVT

Exclusion Criteria

* All participant groups:
Minimum Eligible Age

0 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Turku

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anna Axelin

Professor, Head of Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Turku

Turku, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

AJDAR ULLAH

Role: primary

(+358)404776970

susanna Likitalo

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FIMEA/2025/002511-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Differentiate AVNRT from Orthodromic AVRT
NCT06671145 NOT_YET_RECRUITING NA
Ventricular Tachycardia Cohort
NCT07149701 NOT_YET_RECRUITING